EUPAC FundREREX
Type
Mutual fund
Peer group
International equity
Net assets
$126.8B
Expense ratio
0.82%
1-year return
+23.5%
3 years, a year
+17.1%
5 years, a year
+5.3%
Holdings
387
What it aims to do.
The funds investment objective is to provide you with long-term growth of capital.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Taiwan Semiconductor Manufacturing Co Ltd | 7.13% |
| Capital Group Central Cash Fund | 4.26% |
| Sk Hynix Inc | 2.20% |
| CVE Cenovus Energy Inc | 1.99% |
| Asml Holding Nv | 1.69% |
| Airbus Se | 1.61% |
| Astrazeneca Plc | 1.59% |
| Unicredit Spa | 1.36% |
| Softbank Group Corp | 1.22% |
| Sse Plc | 1.14% |
More on REREX.
- REREX overview
- REREX holdings
- REREX risk
- REREX costs
- REREX money in and out
- REREX share classes
- Compare REREX with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.